Moody Aldrich Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-47,035
| Closed | -$2.28M | – | 154 |
|
|
2020
Q2 | $2.28M | Sell |
47,035
-73,181
| -61% | -$3.55M | 0.48% | 78 |
|
|
2020
Q1 | $5.08M | Sell |
120,216
-170
| -0.1% | -$7.18K | 1.53% | 18 |
|
|
2019
Q4 | $5.15M | Buy |
120,386
+23,147
| +24% | +$990K | 1.06% | 29 |
|
|
2019
Q3 | $3.5M | Buy |
97,239
+63,493
| +188% | +$2.29M | 0.93% | 45 |
|
|
2019
Q2 | $902K | Sell |
33,746
-26,263
| -44% | -$702K | 0.23% | 90 |
|
|
2019
Q1 | $1.61M | Sell |
60,009
-38,797
| -39% | -$1.04M | 0.45% | 84 |
|
|
2018
Q4 | $1.6M | Buy |
98,806
+5,921
| +6% | +$95.8K | 0.52% | 73 |
|
|
2018
Q3 | $1.93M | Buy |
+92,885
| New | +$1.93M | 0.56% | 79 |
|
|
2018
Q1 | – | Sell |
-35,701
| Closed | -$1.08M | – | 87 |
|
|
2017
Q4 | $1.08M | Buy |
35,701
+6,782
| +23% | +$204K | 0.87% | 56 |
|
|
2017
Q3 | $1.09M | Buy |
28,919
+10,304
| +55% | +$388K | 1.12% | 42 |
|
|
2017
Q2 | $519K | Buy |
+18,615
| New | +$519K | 0.65% | 75 |
|
|
2016
Q4 | – | Sell |
-19,110
| Closed | -$608K | – | 89 |
|
|
2016
Q3 | $608K | Buy |
+19,110
| New | +$608K | 0.42% | 90 |
|